Skip to main content
. Author manuscript; available in PMC: 2016 Mar 13.
Published in final edited form as: ACS Infect Dis. 2015 Jan 21;1(3):140–148. doi: 10.1021/id5000458

Figure 2.

Figure 2

Screen of a focused helicase inhibitor library (A) Each compound was tested twice, and the result from the first assay (x-axis) was compared to the result from the second (y-axis) to assess assay reproducibility. (B) Concentration–response assays with selected inhibitors in the benzothiazole class. (C) Concentration–response assays with representatives of the pyrrolone class of compounds. In panels B and C results are compared with data obtained with the potent nonspecific helicase inhibitor ATA (dotted lines).